Cite
Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
MLA
Irving F. Hoffman, et al. Safety and Immunogenicity of the RTS,S/AS01 Malaria Vaccine in Infants and Children Identified as HIV-Infected during a Randomized Trial in Sub-Saharan Africa. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5de7dca589347c24bc0a07f1f5917258&authtype=sso&custid=ns315887.
APA
Irving F. Hoffman, Patricia Njuguna, Opokua Ofori-Anyinam, Pauline Akoo, Kwaku Poku Asante, Portia Kamthunzi, Walter Otieno, Miguel A. Lanaspa, Anangisye Malabeja, Godfrey Allan Otieno, Daniel Ansong, James A. Berkley, Halidou Tinto, John Lusingu, Mary J. Hamel, Selidji T Agnandji, Hermann Sorgho, Bertrand Lell, Nahya Salim Masoud, … Yolanda Guerra Mendoza. (2020). Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa.
Chicago
Irving F. Hoffman, Patricia Njuguna, Opokua Ofori-Anyinam, Pauline Akoo, Kwaku Poku Asante, Portia Kamthunzi, Walter Otieno, et al. 2020. “Safety and Immunogenicity of the RTS,S/AS01 Malaria Vaccine in Infants and Children Identified as HIV-Infected during a Randomized Trial in Sub-Saharan Africa,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5de7dca589347c24bc0a07f1f5917258&authtype=sso&custid=ns315887.